Physician profile
Lisa R Walker
NPI 1912340902
$10,787.18
in general payments reported to CMS, 2019-2025
43 companies · $1,916 in 2025
The $1,916 reported for 2025 was more than what 93% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,369 · 2022: $2,156 · 2023: $2,111 · 2024: $2,236 · 2025: $1,916.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,250 · Education: $12.16.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,250.22 |
| Education | $12.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,387.83 | 2021-2025 | |
| Lundbeck LLC | $1,951.22 | 2021-2025 | Vyepti |
| Collegium Pharmaceutical, INC. | $947.97 | 2021-2025 | Xtampza, Belbuca |
| Pfizer INC. | $764.98 | 2023-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $454.15 | 2021-2025 | Relistor |
| Amgen INC. | $394.12 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $364.08 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $242.86 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $193.08 | 2021-2023 | Trintellix |
| Axsome Therapeutics, INC. | $191.63 | 2024-2025 | Auvelity, Symbravo |
| Lilly USA, LLC | $178.76 | 2021-2025 | Emgality, Reyvow |
| Novartis Pharmaceuticals Corporation | $167.58 | 2021 | |
| Impel Pharmaceuticals INC. | $164.37 | 2022-2023 | Trudhesa |
| Biohaven Pharmaceuticals, INC. | $160.28 | 2021 | |
| Novo Nordisk INC | $144.13 | 2022 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.